PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS

被引：0
|
作者：
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
EGFR mutations; Kras mutations; BRAF mutations; molecular diagnostics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1533 / S1534
页数：2
相关论文
共 50 条
  • [21] Prevalence of EGFR Mutations in Brazilian Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
    Lima, Ellias Abreu
    Sales, Paulo Guilherme
    Vilaca, Israel
    Perillo, Fernanda
    Almeida, Flavia
    Martins, Graziella
    Goncalves, Mariana
    Toledo, Joseane
    Giovani, Poliana
    Silva, Wania
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1443 - S1444
  • [22] Acquired EGFR-resistant mutations in non-small cell lung cancer (NSCLC).
    Raez, Luis E.
    Baca, Yasmine
    Nieva, Jorge J.
    Mamdani, Hirva
    Lopes, Gilberto
    Borghaei, Hossein
    Socinski, Mark A.
    Nabhan, Chadi
    Wozniak, Antoinette J.
    Vanderwalde, Ari M.
    Uribe, Carlos Carracedo
    Khan, Hina
    Liu, Stephen V.
    Nagasaka, Misako
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    APMIS, 2012, 120 : 14 - 14
  • [24] Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing
    Liu, Yan
    Wu, Bing-Quan
    Zhong, Hao-Hao
    Hui, Pei
    Fang, Wei-Gang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (09): : 1880 - 1889
  • [25] Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Heideman, Danielle A. M.
    van Suylen, Robertjan
    Thunnissen, Frederik B.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [26] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [27] Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
    Sun, Jong-Mu
    Hwang, Deok Won
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    PLOS ONE, 2013, 8 (05):
  • [28] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    Medical Oncology, 2014, 31
  • [29] Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
    Becker, Caroline
    Carcereny Costa, Enric
    Andreo Garcia, Felipe
    Castella, Eva
    Lletjos Sanuy, Mariona
    Moran, Teresa
    Mijangos Basterra, Erika
    Sanz Santos, Jose
    Centeno Clemente, Carmen
    Ruiz Manzano, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [30] PROGNOSTIC AND PREDICTIVE VALUE OF KRAS MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hwang, Deok Won
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1075 - S1075
12345